Amanote Research
Register
Sign In
Factors Associated With Delayed Time to Adjuvant Chemotherapy in Stage Iii Colon Cancer
Current Oncology
- Canada
doi 10.3747/co.21.1963
Full Text
Open PDF
Abstract
Available in
full text
Categories
Oncology
Date
May 16, 2014
Authors
A. Chan
R. Woods
H. Kennecke
S. Gill
Publisher
MultiMed Inc.
Related search
2-Year Single Center Clinical Experience in Patients With Colon Cancer Stage II and III Receiving Adjuvant Chemotherapy
Scripta Scientifica Medica
Adjuvant Chemotherapy Does Not Provide Survival Benefits to Elderly Patients With Stage II Colon Cancer
Scientific Reports
Multidisciplinary
Stage III Colon Cancer: The Individualized Strategy of Adjuvant Chemotherapy for Aged Under and Over 70
PLoS ONE
Multidisciplinary
Oncologic Outcomes of Oral Adjuvant Chemotherapy Regimens in Stage III Colon Cancer: Tegafur–Uracil Plus Leucovorin Versus Capecitabine
Clinical Colorectal Cancer
Oncology
Gastroenterology
Comparison of Adverse Events During 5-Fluorouracil Versus 5-Fluorouracil/Oxaliplatin Adjuvant Chemotherapy for Stage III Colon Cancer
Cancer
Cancer Research
Oncology
P53 Expression Status Is Associated With Cancer-Specific Survival in Stage III and High-Risk Stage II Colorectal Cancer Patients Treated With Oxaliplatin-Based Adjuvant Chemotherapy
British Journal of Cancer
Cancer Research
Oncology
The Survival Impact of Delayed Surgery and Adjuvant Chemotherapy on Stage II/III Rectal Cancer With Pathological Complete Response After Neoadjuvant Chemoradiation
International Journal of Cancer
Cancer Research
Oncology
Survival Analysis of Adjuvant Chemotherapy With S-1 Plus Cisplatin for Stage III Gastric Cancer
Gastric Cancer
Cancer Research
Medicine
Oncology
Gastroenterology
Effect of Adjuvant Chemotherapy on Stage II Colon Cancer: Analysis of Korean National Data
Cancer Research and Treatment
Cancer Research
Oncology
